Myelophthisic anemia is anemia caused by abnormal tissue invading and replacing the bone marrow, so the marrow can no longer make enough blood cells. The invading tissue is most often cancer that has spread from elsewhere, but fibrosis, infections, and some storage disorders can do the same. It usually shows up as anemia with a distinctive blood smear, and treatment focuses on the underlying cause.
What Is Myelophthisic Anemia?
The word comes from Greek roots meaning “marrow” and “wasting.” The healthy marrow space is filled with blood-forming (hematopoietic) cells supported by a delicate framework. In myelophthisis, that space is taken over by something else, such as tumor cells, scar-like fibrous tissue, or granulomas.
Two things follow. First, fewer red cells, white cells, and platelets are produced. Second, the invading tissue disrupts the marrow’s normal barrier, so immature cells escape into the bloodstream early. This combination gives the condition its characteristic laboratory picture. It belongs to the wider group of hematological disorders that arise from marrow failure rather than from blood loss or destruction.
Causes and Underlying Mechanisms
Any process that physically occupies the marrow can cause myelophthisic anemia. To understand why this is so damaging, it helps to recall the role of bone marrow in blood cell production: nearly all adult blood cells are made there.
| Category | Examples |
|---|---|
| Metastatic solid tumors | Breast, prostate, and lung cancer in adults; neuroblastoma in children |
| Blood cancers | Lymphoma, multiple myeloma, leukemia |
| Marrow fibrosis | Primary myelofibrosis; secondary fibrosis from other diseases |
| Granulomatous infections and inflammation | Tuberculosis, disseminated fungal infection, sarcoidosis |
| Storage disorders | Gaucher disease and related lipid storage diseases |
| Bone disorders | Osteopetrosis, in which dense bone crowds out the marrow cavity |
Why the blood looks the way it does
As the marrow fails, the body tries to make blood elsewhere, mainly in the spleen and liver. This is called extramedullary hematopoiesis. These sites lack the marrow’s quality control, and the distorted marrow framework also squeezes cells as they exit. Both effects release immature and misshapen cells into the circulation.
Signs and Symptoms
Symptoms tend to develop gradually and overlap with those of other anemias. Many people first notice the effects of the underlying disease, such as bone pain from metastases or weight loss from a lymphoma. Common features include:
- Fatigue, weakness, and breathlessness on exertion from anemia
- Pale skin
- Easy bruising, nosebleeds, or bleeding gums from low platelets
- Frequent or unusual infections from low white cells
- Fullness or discomfort under the left ribs from an enlarged spleen
- Bone pain, fevers, night sweats, or unintended weight loss, depending on the cause
When all three cell lines fall together, the result is pancytopenia, a reduction across all types of blood cells. However, counts can be only mildly reduced early on, which is why the blood smear is so important.
Diagnosis and Testing
Blood count and blood smear
The complete blood count usually shows a normocytic anemia (normal-sized red cells) with a low reticulocyte count, often with low platelets and variable white cells. The hallmark is a leukoerythroblastic blood picture on the smear, which combines:
- Nucleated red blood cells, which are normally found only in the marrow
- Immature white cells such as myelocytes and metamyelocytes
- Teardrop cells (dacrocytes), red cells deformed as they squeeze out of the abnormal marrow
Teardrop erythrocytes are not unique to myelophthisis, but seeing them with nucleated red cells in an adult should always prompt investigation of the marrow.
Bone marrow aspirate and biopsy
A marrow examination confirms the diagnosis and usually reveals the cause. The needle aspirate is often a “dry tap,” meaning little or no liquid marrow can be drawn because the space is packed with tumor or fibrosis. The core (trephine) biopsy is therefore essential. It can show clusters of metastatic cancer, lymphoma, granulomas, or increased reticulin and collagen fibers. Special stains, cultures, and molecular tests then identify the exact cause.
Other investigations
Depending on the suspected cause, doctors may order imaging such as CT, PET, or bone scans to look for a primary tumor or metastases, tumor markers, serum protein studies for myeloma, and tests for tuberculosis or fungal infection. Deficiencies of iron, vitamin B12, and folate are checked and corrected so they do not confuse the picture.
Treatment Options
There is no treatment aimed at myelophthisis as such. The goal is to control whatever is occupying the marrow while supporting the blood counts in the meantime.
Treating the underlying cause
- Metastatic cancer: chemotherapy, hormone therapy (for example in breast or prostate cancer), targeted drugs, or immunotherapy, chosen by the oncology team
- Lymphoma and myeloma: disease-specific regimens, which can clear the marrow and allow counts to recover
- Tuberculosis or fungal infection: appropriate antimicrobial treatment
- Sarcoidosis: corticosteroids or other immune-modulating medicines when needed
- Myelofibrosis: specialist therapies, and in selected patients stem cell transplantation
Supportive care
Red cell transfusions relieve symptoms of anemia, and platelet transfusions help manage or prevent bleeding. Infections are treated promptly, and growth factors may be used in certain situations. Because cancer treatments can themselves suppress the marrow, the care team balances treatment intensity against blood counts. For a broader view of how the marrow works and fails, see our bone marrow guide.
Key Takeaways
- Myelophthisic anemia results from the marrow being physically replaced by tumor, fibrosis, granulomas, or storage cells.
- The classic clue is a leukoerythroblastic smear with teardrop cells and nucleated red cells.
- A bone marrow biopsy is usually needed, because aspiration often yields a dry tap.
- Outlook depends on the underlying cause, and treatment targets that cause plus supportive transfusions.
Like other hematologic disorders, it is best managed by a team that includes hematology, oncology, and other specialists as needed. Anyone with unexplained anemia, bruising, or bone pain should see a doctor for a blood count.
Frequently Asked Questions
Is myelophthisic anemia a type of cancer?
No. It is a consequence of something else in the marrow, which is often, but not always, cancer. Infections, fibrosis, and storage diseases can cause it too.
What does a teardrop cell on a blood smear mean?
Teardrop cells form when red cells are deformed while leaving an abnormal marrow or passing through an enlarged spleen. They are a classic feature of marrow infiltration and myelofibrosis, so they prompt further testing.
Can the bone marrow recover?
It can if the underlying cause responds to treatment. Clearing lymphoma, myeloma, or an infection from the marrow often allows normal blood production to return over weeks to months.
Why was my bone marrow aspirate a “dry tap”?
A dry tap means no liquid marrow could be drawn, usually because the space is packed with fibrous tissue or tumor cells. A core biopsy taken at the same time provides the diagnosis instead.
